Structure Therapeutics, Inc. Sponsored ADR Financial Overview
Structure Therapeutics, Inc. Sponsored ADR's market cap is currently $4.13B. The company's EPS TTM is $-0.37; its P/E ratio is -18.65; Structure Therapeutics, Inc. Sponsored ADR is scheduled to report earnings on November 6, 2025, and the estimated EPS forecast is $-0.38. See an overview of income statement, balance sheet, and cash flow financials.
